Literature DB >> 2018532

Gravidin, an endogenous inhibitor of phospholipase A2 activity, is a secretory component of IgA.

T Wilson1, D L Christie.   

Abstract

Gravidin, a phospholipase inhibitor characterised previously from amniotic fluid, was partially sequenced at the N-terminal and found to be identical to secretory component of human IgA. Inhibition of antiphospholipase activity was observed after incubation of gravidin with monoclonal antibody to human secretory component. Secretory component isolated from human saliva and breast milk was found to inhibit arachidonic acid release from human lymphocytes. It was concluded that gravidin is secretory component of IgA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018532     DOI: 10.1016/0006-291x(91)90944-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Decreased inhibition by gravidin of arachidonate release from transformed compared to nontransformed cells.

Authors:  T Wilson; R K Ralph; R Ganendren
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

2.  Secretory component (polymeric immunoglobulin receptor) as an intrinsic inhibitor of biological functions of interferon gamma in keratinocytes.

Authors:  Y Nihei; K Maruyama; J Z Zhang; K Kobayashi; F Kaneko
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 3.  Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjögren's syndrome.

Authors:  D A Sullivan; E H Sato
Journal:  Clin Immunol Immunopathol       Date:  1992-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.